Does it matter where you inject Wegovy, and does the site change how it works?

You've uncapped your pen, but where exactly should it go?

Picture the moment: pen in hand, ready to inject, and suddenly uncertain whether the thigh or abdomen makes any real difference. It's a question our prescribers hear regularly, and the honest answer is that it matters more than most people assume.

All three licensed sites (abdomen, front of the thigh, and the outer upper arm) deliver semaglutide into the layer of fatty tissue just beneath the skin. That subcutaneous fat acts as a slow-release reservoir, which is exactly what a once-weekly medicine needs. But the thickness and blood-flow profile of that fat layer varies between sites, which is why absorption is fastest and most consistent from the abdomen. The thigh and upper arm are reliable alternatives, not fallbacks.

A practical checking habit worth building: before each injection, run a finger over the area you're about to use. Skin that feels firm, lumpy, or tender is telling you something. Inject into it anyway and you risk slower absorption, more discomfort, and over time a condition called lipohypertrophy, a localised fatty lump that forms when the same patch of tissue is repeatedly stressed. Spend ten seconds on this check and you'll notice problems before they start.

The NHS guidance on where to inject Wegovy is clear that rotating between sites every week is not optional guidance, it is part of using the medicine correctly. That means if you used your right abdomen last week, moving to your thigh or upper arm this week is the right call, and cycling back is fine once the tissue has had time to recover.

Does where you inject Wegovy affect how well it works?

The short answer is: it can affect absorption, and absorption affects how reliably the medicine does its job.

Semaglutide's mechanism depends on stable blood levels week to week, it works by activating GLP-1 receptors that regulate appetite and slow gastric emptying, as described in the NHS semaglutide medicines guide. Large swings in absorption between doses can make side effects less predictable and, in theory, reduce how consistently you experience the appetite-reducing effect.

This is why the abdomen is usually the recommended starting point for people new to Wegovy. Abdominal fat, particularly around the lower belly area, tends to offer a consistent tissue environment. If you are lean with little subcutaneous abdominal fat, the thigh may actually be a better choice, your prescriber can advise on this. The upper arm is a practical site if you find self-injection into the abdomen or thigh awkward, though some people find it easier with assistance.

One nuance worth knowing: if you are also taking an oral contraceptive pill and have recently started or increased your Wegovy dose, the NHS England guidance on weight management injections notes that for tirzepatide specifically, reduced pill absorption is a consideration, the evidence is less clear for semaglutide, but it is still worth discussing with your prescriber. Injection site choice does not change this interaction, but it is a reason to keep your clinical team informed about everything you take alongside Wegovy.

If you want to understand whether injection sites matter for semaglutide and how the clinical evidence stacks up, that page covers the detail in more depth across GLP-1 medicines more broadly.

Mistakes that matter and how to avoid them

Most injection-site problems are preventable. The ones our clinical team see most often come down to a small number of repeatable errors.

Injecting into the same small zone repeatedly is the most common. It is understandable, you find a spot that worked, it was painless, and you return to it. Within a few weeks, though, that tissue becomes harder and less vascular. Absorption slows and the area can become uncomfortable. A simple rotation pattern (abdomen one week, right thigh the next, left thigh the week after, upper arm after that) removes the guesswork entirely.

Injecting into cold skin is another one. If your pen has come straight from the fridge, the semaglutide solution is at 2–8°C. Injecting cold fluid into tissue stings noticeably more than injecting at room temperature. Letting the pen sit at room temperature for 15–30 minutes before use is a small change that makes a real difference, always check your Patient Information Leaflet for the exact guidance on how long this is safe, as that window is product-specific and not something to guess at.

Pressing too hard, angling incorrectly, or injecting into clothes without first accessing bare skin are also common in the early weeks. The Wegovy pen is designed for straightforward use, but the technique still has a few specifics. If you would like to understand the thigh as a site in more detail, the guide to injecting Wegovy in the leg is a useful reference.

Finally, needle changes matter. Using the same needle more than once blunts the tip, increases injection discomfort, and raises infection risk. Fresh needles are a basic part of safe injection practice, if you need a reminder of what to have on hand, replacement needles are available from our pharmacy.

If you are considering starting Wegovy and want to understand the cost alongside the clinical side, our Wegovy pricing guide explains what to expect. When you are ready to speak to a prescriber, check your eligibility with our clinical team, consultations are free, reviewed the same day by a GPhC-registered prescriber, and there is no obligation.